The fact sheet contains information in areas such as indications, contraindications, warnings and cautions, adverse effects and details about the vaccination programme.
The reference section provides links to other key resources including the European Medicines Agency portal. This website contains information about the medicines for pandemic influenza (H1N1) including the Summary of Product Characteristics (SPCs) for the three currently licensed vaccines available in Europe (Celvapan®, Focetria®, Pandemrix®) and antivirals (Tamiflu®, Relenza®).
Action: Clinicians will find plenty of useful information in these resources.
|« DTB advises against aspirin for primary prevention||Non-fasting cholesterol tests? »|